No Data
No Data
10-Q: Q2 2024 Earnings Report
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights Into Bipolar Disorder Pathways and Potential Drug Targets
Join BullFrog AI's Exclusive Live Investor Webinar and Q&A Session on June 12
Express News | Bullfrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
10-Q: Q1 2024 Earnings Report
BullFrog AI's CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
No Data